Ha habido 50 transacciones internas recientes registradas para Milestone Pharmaceuticals Inc. (MIST), incluyendo 35 compras y 12 ventas. El total de compras internas fue valorado en $5.4M y el total de ventas internas en $958.19K.
Internos destacados con actividad reciente incluyen Sandoval David I., Oliveto Joseph, Muller Lorenz. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — MIST
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-17 |
Sandoval David I. |
Gc & Chief Compliance Officer |
Desconocido |
400,000 |
$1.96 |
$784K |
- |
| 2026-02-02 |
Oliveto Joseph |
President and CEO |
Concesión de RSU |
453,000 |
- |
- |
453,000 |
| 2026-02-02 |
Muller Lorenz |
Chief Commercial Officer |
Concesión de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Hasija Amit |
CFO & EVP of Corp. Development |
Concesión de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Bharucha David |
Chief Medical Officer |
Concesión de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Concesión de RSU |
136,000 |
- |
- |
136,000 |
| 2026-02-02 |
Oliveto Joseph |
President and CEO |
Concesión de RSU |
679,000 |
$1.96 |
$1.33M |
679,000 |
| 2026-02-02 |
Muller Lorenz |
Chief Commercial Officer |
Concesión de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Hasija Amit |
CFO & EVP of Corp. Development |
Concesión de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Bharucha David |
Chief Medical Officer |
Concesión de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-02-02 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Concesión de RSU |
204,000 |
$1.96 |
$399.84K |
204,000 |
| 2026-01-26 |
Oliveto Joseph |
President and CEO |
Ejercicio de Opciones (Venta) |
66,600 |
- |
- |
199,800 |
| 2026-01-26 |
Muller Lorenz |
Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Hasija Amit |
CFO & EVP of Corp. Development |
Ejercicio de Opciones (Venta) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Bharucha David |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
20,100 |
- |
- |
60,300 |
| 2026-01-26 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Venta Informativa |
12,245 |
$1.93 |
$23.63K |
49,848 |
| 2026-01-08 |
Oliveto Joseph |
President and CEO |
Venta Informativa |
43,000 |
$2.25 |
$96.75K |
303,721 |
| 2026-01-07 |
Oliveto Joseph |
President and CEO |
Venta Informativa |
500 |
$2.25 |
$1.13K |
346,721 |
| 2025-12-15 |
Oliveto Joseph |
President and CEO |
Venta Informativa |
133,054 |
$2.32 |
$308.69K |
450,667 |
| 2025-12-15 |
Muller Lorenz |
Chief Commercial Officer |
Venta Informativa |
53,566 |
$2.32 |
$124.27K |
196,486 |
| 2025-12-15 |
Hasija Amit |
CFO & EVP of Corp. Development |
Venta Informativa |
58,007 |
$2.32 |
$134.58K |
91,993 |
| 2025-12-15 |
Bharucha David |
Chief Medical Officer |
Venta Informativa |
58,007 |
$2.32 |
$134.58K |
105,326 |
| 2025-12-15 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Venta Informativa |
58,007 |
$2.32 |
$134.58K |
41,993 |
| 2025-12-12 |
Oliveto Joseph |
President and CEO |
Concesión de RSU |
280,000 |
$1.74 |
$487.2K |
280,000 |
| 2025-12-12 |
Muller Lorenz |
Chief Commercial Officer |
Concesión de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Hasija Amit |
CFO & EVP of Corp. Development |
Concesión de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Bharucha David |
Chief Medical Officer |
Concesión de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-12 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Concesión de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2025-12-09 |
Muller Lorenz |
Chief Commercial Officer |
Donación (Otorgada) |
25,000 |
- |
- |
150,052 |
| 2025-07-11 |
Papa Joseph C |
Director |
Concesión de RSU |
100,000 |
$1.88 |
$187.5K |
100,000 |
| 2025-07-11 |
Oliveto Joseph |
President and CEO |
Concesión de RSU |
66,666 |
$1.88 |
$125K |
66,666 |
| 2025-07-11 |
Wills Robert James |
Director |
Concesión de RSU |
50,000 |
$1.50 |
$75K |
50,000 |
| 2025-07-11 |
Muller Lorenz |
Chief Commercial Officer |
Concesión de RSU |
66,666 |
$1.50 |
$100K |
66,666 |
| 2025-07-11 |
Liebert Debra K. |
Director |
Concesión de RSU |
16,666 |
$1.50 |
$25K |
16,793 |
| 2025-07-11 |
Hasija Amit |
CFO & EVP of Corp. Development |
Concesión de RSU |
50,000 |
$1.50 |
$75K |
50,000 |
| 2025-07-11 |
Bharucha David |
Chief Medical Officer |
Concesión de RSU |
53,333 |
$1.88 |
$100K |
53,333 |
| 2025-06-10 |
Papa Joseph C |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Giles Lisa M. |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Tomsicek Michael John |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Fischer Seth H. Z. |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Saik Andrew |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Wills Robert James |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-06-10 |
Duty Stuart |
Director |
Concesión de RSU |
40,000 |
$1.75 |
$70K |
40,000 |
| 2025-01-27 |
Oliveto Joseph |
President and CEO |
Concesión de RSU |
266,400 |
- |
- |
266,400 |
| 2025-01-27 |
Muller Lorenz |
Chief Commercial Officer |
Concesión de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Hasija Amit |
CFO & EVP of Corp. Development |
Concesión de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Bharucha David |
Chief Medical Officer |
Concesión de RSU |
80,400 |
- |
- |
80,400 |
| 2025-01-27 |
Nelson Jeffrey Edward |
Chief Operating Officer |
Concesión de RSU |
80,400 |
- |
- |
80,400 |
| 2024-09-03 |
Papa Joseph C |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-09-03 |
Papa Joseph C |
Director |
Concesión de RSU |
80,000 |
$1.39 |
$111.2K |
80,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
